Marc Tessier-Lavigne

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Tyler Nielsen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc Tessier-Lavigne:

Company Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. Director Common Stock 1,886,576 $31,015,309 $16.44 03 Jun 2025 Direct
REGENERON PHARMACEUTICALS, INC. Director Common Stock 2,434 $2,315,367 $951.26 03 Jan 2023 Direct
Denali Therapeutics Inc. Director Common Stock 79,173 $1,301,604 $16.44 03 Jun 2025 The Tessier-Lavigne/Hynes Irrevocable Trust 2
Denali Therapeutics Inc. Director Common Stock 78,848 $1,296,261 $16.44 03 Jun 2025 The Tessier-Lavigne/Hynes Irrevocable Trust 1
Denali Therapeutics Inc. Director Common Stock 78,848 $1,296,261 $16.44 03 Jun 2025 The Tessier-Lavigne/Hynes Irrevocable Trust 3
Denali Therapeutics Inc. Director Stock Option (right to buy) 18,111 03 Jun 2025 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 1,929 03 Jan 2023 Direct

Insider Reports Filed by Marc Tessier-Lavigne

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNLI Denali Therapeutics Inc. 03 Jun 2025 2 $0 4 Director 05 Jun 2025, 16:23
DNLI Denali Therapeutics Inc. 31 May 2024 2 $0 4 Director 04 Jun 2024, 18:31
DNLI Denali Therapeutics Inc. 01 Jun 2023 2 $0 4 Director 05 Jun 2023, 18:06
REGN REGENERON PHARMACEUTICALS, INC. 03 Jan 2023 2 $0 4 Director 05 Jan 2023, 15:16
REGN REGENERON PHARMACEUTICALS, INC. 03 Jan 2023 2 $0 4 Director 05 Jan 2023, 15:16
DNLI Denali Therapeutics Inc. 23 Nov 2022 1 -$609,600 4 Director 28 Nov 2022, 18:30
DNLI Denali Therapeutics Inc. 01 Nov 2022 2 -$605,463 4 Director 03 Nov 2022, 17:37
REGN REGENERON PHARMACEUTICALS, INC. 29 Sep 2022 20 -$3,131,174 4 Director 03 Oct 2022, 16:05
DNLI Denali Therapeutics Inc. 28 Sep 2022 2 -$616,304 4 Director 30 Sep 2022, 16:50
DNLI Denali Therapeutics Inc. 23 Aug 2022 2 -$632,282 4 Director 25 Aug 2022, 18:11
DNLI Denali Therapeutics Inc. 25 Jul 2022 2 -$712,110 4 Director 27 Jul 2022, 18:49
DNLI Denali Therapeutics Inc. 23 Jun 2022 3 -$1,843,045 4 Director 27 Jun 2022, 20:54
DNLI Denali Therapeutics Inc. 02 Jun 2022 2 $0 4 Director 06 Jun 2022, 20:09
DNLI Denali Therapeutics Inc. 23 Mar 2022 2 -$676,583 4/A Director 28 Jun 2022, 15:07
REGN REGENERON PHARMACEUTICALS, INC. 21 Mar 2022 3 -$2,299,023 4 Director 23 Mar 2022, 16:01
REGN REGENERON PHARMACEUTICALS, INC. 16 Mar 2022 6 -$3,687,055 4 Director 18 Mar 2022, 16:05
REGN REGENERON PHARMACEUTICALS, INC. 03 Jan 2022 2 $0 4 Director 05 Jan 2022, 15:23
DNLI Denali Therapeutics Inc. 31 Dec 2021 1 $0 5 Director 17 Feb 2022, 19:25
DNLI Denali Therapeutics Inc. 28 Dec 2021 16 -$2,805,197 4 Director 30 Dec 2021, 20:59
REGN REGENERON PHARMACEUTICALS, INC. 09 Dec 2021 3 -$1,110,982 4 Director 10 Dec 2021, 16:41
REGN REGENERON PHARMACEUTICALS, INC. 13 Sep 2021 23 -$4,692,534 4 Director 15 Sep 2021, 16:02
DNLI Denali Therapeutics Inc. 07 Jun 2021 8 -$4,874,248 4 Director 08 Jun 2021, 17:10
DNLI Denali Therapeutics Inc. 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 18:37
DNLI Denali Therapeutics Inc. 21 May 2021 2 -$2,811,048 4 Director 24 May 2021, 20:05